Surfactant induced glistenings: Surface active ingredients in ophthalmic solutions may enhance water entry into the voids of implanted acrylic intraocular lenses

Journal of Long-Term Effects of Medical Implants

Volumn 16, Issue 6, 2006, Pages 451-457

  Ayaki, Masahiko ^a   Nishihara, Hitoshi ^a   Yaguchi, Shigeo ^a   Koide, Ryohei ^b  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cataract; Glistenings; Ingredients; Light scattering

Indexed keywords

LENSES; LIGHT SCATTERING; PHOTOGRAPHY; SURFACE ACTIVE AGENTS;

ACRYLIC INTRAOCULAR LENSES (IOL); CATARACT; INGREDIENTS; OPHTHALMIC SOLUTIONS;

OPHTHALMOLOGY;

AGENTS ACTING ON THE EYE; BENZALKONIUM CHLORIDE; BETAMETHASONE; BETAMETHASONE SODIUM PHOSPHATE; BORATE SODIUM; BORIC ACID; CHLORBUTOL; DIBEKACIN; DICLOD; DICLOFENAC; HYALURONIC ACID; METHYL PARABEN; POLYSORBATE; POLYSORBATE 80; POVIDONE; PROPYL PARABEN; SODIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE; SODIUM SULFATE; SURFACTANT; UNCLASSIFIED DRUG; ACRYLIC ACID RESIN; ANTIINFECTIVE AGENT; EYE DROPS; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ANTIINFLAMMATORY ACTIVITY; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LENS IMPLANT; LENS IMPLANTATION; LIGHT SCATTERING; MAJOR CLINICAL STUDY; MALE; WATER TRANSPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ACRYLIC RESINS; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETAMETHASONE; DIBEKACIN; DICLOFENAC; FEMALE; HUMANS; LENSES, INTRAOCULAR; MALE; OPHTHALMIC SOLUTIONS; SURFACE-ACTIVE AGENTS;

EID: 38449084612     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v16.i6.50     Document Type: Article

References (18)

1. Dhaliwal DK, Mamalis N, Olson RJ, Crandall AS, Zimmerman P, Alldredge OC, Durcan FJ, Omar O. Visual significance of glistenings seen in the AcrySof intraocular lens. J Cataract Refract Surg. 1996;22:452-7.
2. Omar O, Pirayesh A, Mamalis N, Olson RJ. In vitro analysis of AcrySof intraocular lens glistenings in AcryPak and Wagon-Wheel packaging. J Cataract Refract Surg. 1998;24:107-13.
3. Miyata A, Uchida N, Nakajima K, Yaguchi S. Clinical and experimental observation of glistening in acrylic intraocular lenses. Jpn J Ophthalmol. 2001;45:564-9.
4. Kato K, Nishida M, Yamane H, Nakamae K, Tagami Y, Tetsumoto K. Glistening formation in an AcrySof lens initiated by spinodal decomposition of the polymer network by temperature change. J Cataract Refract Surg. 2001;27:1493-8.
5. Tognetto D, Toto L, Sanguinetti G, Ravalico G. Glistenings in foldable intraocular lenses. J Cataract Refract Surg. 2002;28:1211-6.
6. Oshika T, Shiokawa Y, Amano S, Mitomo K. Influence of glistenings on the optical quality of acrylic foldable intraocular lens. Br J Ophthalmol. 2001;85:1034-7.
7. Dick HB, Olson RJ, Augustin AJ, Schwenn O, Magdowski G, Pfeiffer N. Vacuoles in the Acrysof™ intraocular lens as factor of the presence of serum in aqueous humor. Ophthalmic Res. 2001;33:61-7.
8. Nishihara H, Yaguchi S, Onishi T, Chida M, Ayaki M. Newly observed surface scattering in implanted hydrophobic intraocular lenses. J Cataract Refract Surg. 2003;29:1385-8.
9. Ronen S, Rozenman Y, Zylbermann R, Berson D. Treatment of ocular inflammation with diclofenac sodium: Double-blind trial following cataract surgery. Am J Ophthalmol. 1985;17:577-81.
10. Roberts CW Brennan KM. A comparison of topical diclofenac with prednisolone for postcataract inflammation. Arch Ophthalmol. 1995;113:725-7.
11. Kato S, Boku C, Onishi T, Koike M, Kageyama T, Nishihara H, Yaguchi S. Comparison of postoperative inflammation with two types of intraocular lenses and anti-inflammatory agents. Folia Ophthalmol Jpn. 1998;49:286-9.
12. Miyake K, Masuda K, Shirato S, Oshika T, Eguchi K, Hoshi H, Majima Y, Kimura W, Hayashi F. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: A multicentered prospective trial. Jpn J Ophthalmol. 2000;44:58-67.
13. Tsuchiya T, Ayaki M, Onishi T, Kageyama T, Yaguchi S: Three years prospective randomized study of incidence of posterior capsule opacification in eyes treated with topical diclofenac and betamethasone Ophthalmic Res. 2003;35:67-70.
14. Hayashi K, Hayashi H, Nakao F, Hayashi F. In vivo quantitative measurement of posterior capsule opacification after extracapsular cataract surgery. Am J Ophthalmol. 1998;125:837-43.
15. Burstein NL. Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Invest Ophthalmol Vis Sci. 1980;19:308-313.
16. D'Angelo G, Lambiase A, Cortes M, Sgrulletta R, Pasqualetti R, Lamagna A, Bonini S. Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis. Graefe's Arch Clin Exp Ophthalmol. 2003;241:192-5.
17. Miyake K, Ota I, Ibaraki N, Akura J, Ichihashi S, Shibuya Y, Maekubo K, Miyake S. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical Timolol and its preservative in early postoperative pseudophakia. Archive Ophthalmol. 2001;119:387-94.
18. Ayaki M, Nishihara H, Yaguchi S, Koide R. Ophthalmic solution ingredients permeate and damage acrylic intraocular lenses. J Cataract Refract Surg. 2007;33:122-6.